Jamp Pentoxifylline SR · DIN 02543087 · 400 mg · extended release tablet
Limited Use, Reason for Use code 76, 529 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 76, 529 required
Write on scriptone applicable Reason for Use code, 76 or 529 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 76, 529
Reason for Use code 76
For the treatment of patients with critical limb ischemia (with arterial ulcers, gangrene and/or rest pain) and documented arterial vascular disease.
Coverage limit:
Limited Use form must specify if arterial ulcers, gangrene and/or rest pain are present.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 529
For the treatment of patients with venous ulcers lasting, or expected to last, more than 8 weeks.
Treatment should be discontinued after 3 months if there is no indication of objective benefit.
The duration of therapy with pentoxifylline should not exceed 12 months.
Coverage limit:
Pentoxifylline should be used in combination with compression therapy.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Jamp Pentoxifylline SR · DIN 02543087
Manufacturer: Jamp Pharma Corporation; listing date 2024-11-29
Health Canada: Marketed since 2024-09-20 · brand JAMP PENTOXIFYLLINE SR · ATC C04AD03 PENTOXIFYLLINE · form Tablet (extended-release) · route Oral · ingredients PENTOXIFYLLINE 400 MG · company Jamp pharma corporation · schedule Prescription
Jamp Pentoxifylline SR: Formulary list price $0.72 per unit (the source does not state the unit; exact figure $0.7238). What the ministry pays, not the patient.
Ministry pays: $0.7238 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02543087)
Source record
DIN 02543087: Jamp Pentoxifylline SR
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 202400001; group id 271; item number 0561; lccId 00049; manufacturer id JPC
Source form: SR Tab; strength: 400mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.7238; ministry $0.7238
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02543087
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103158
Interchangeable products
Apo-Pentoxifylline SR · DIN 02230090 · $0.7238
Trental · DIN 02221977 · not recorded
Shortage status: not checked (no credentials)